| |
| |
|
| Insider
Information: |
Cox Russell J. |
| Relationship: |
Director |
| City: |
Palo Alto |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
117,021 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$11,245,403 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
117,021 |
|
|
| Total
Value |
$11,245,403 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Jazz Pharmaceuticals Inc |
JAZZ |
EVP & COO |
2017-12-11 |
102,821 |
2011-05-31 |
0 |
Premium* |
|
|
Aeglea Biotherapeutics, Inc. |
AGLE |
Director |
2016-04-12 |
7,000 |
2016-04-12 |
0 |
Premium* |
|
|
Gossamer Bio Inc |
GOSS |
Director |
2019-02-12 |
7,200 |
2019-02-12 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| JAZZ |
Jazz Pharmaceuticals Inc |
EVP & Chief Commercial Officer |
• – – |
2012-03-09 |
4 |
S |
$49.56 |
$247,800 |
D/D |
(5,000) |
14,005 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
EVP & Chief Commercial Officer |
• – – |
2014-02-27 |
4 |
S |
$160.00 |
$658,360 |
D/D |
(4,000) |
50,024 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
EVP & COO |
• – – |
2015-03-05 |
4 |
S |
$175.10 |
$87,550 |
D/D |
(500) |
65,053 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
SVP, Sales and Marketing |
• – – |
2012-01-11 |
4 |
OE |
$8.23 |
$1,220,204 |
D/D |
54,800 |
48,088 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
EVP & Chief Commercial Officer |
• – – |
2013-05-20 |
5 |
OE |
$8.23 |
$8,230 |
D/D |
1,000 |
54,024 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
EVP & COO |
• – – |
2017-12-11 |
4 |
OE |
$8.23 |
$691,676 |
D/D |
50,758 |
102,821 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
SVP, Sales and Marketing |
• – – |
2012-01-11 |
4 |
D |
$48.60 |
$1,798,686 |
D/D |
(37,010) |
19,005 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
SVP, Sales and Marketing |
• – – |
2012-01-18 |
4 |
D |
$0.00 |
$0 |
D/D |
(19,005) |
0 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
EVP & Chief Commercial Officer |
• – – |
2013-08-09 |
4 |
D |
$80.88 |
$267,713 |
D/D |
(3,310) |
53,736 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
EVP & Chief Commercial Officer |
• – – |
2014-03-05 |
4 |
D |
$157.60 |
$203,462 |
D/D |
(1,291) |
58,733 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
EVP & Chief Operating Officer |
• – – |
2014-08-11 |
4 |
D |
$133.86 |
$598,756 |
D/D |
(4,473) |
60,059 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
EVP & COO |
• – – |
2015-02-27 |
4 |
D |
$170.09 |
$161,245 |
D/D |
(948) |
67,124 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
EVP & COO |
• – – |
2015-03-05 |
4 |
D |
$174.76 |
$274,548 |
D/D |
(1,571) |
65,553 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
EVP & Chief Commercial Officer |
• – – |
2015-08-07 |
4 |
D |
$181.79 |
$177,791 |
D/D |
(978) |
63,667 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
EVP & Chief Commercial Officer |
• – – |
2015-08-10 |
4 |
D |
$181.48 |
$828,456 |
D/D |
(4,565) |
59,102 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
EVP & COO |
• – – |
2016-02-26 |
4 |
D |
$125.00 |
$91,375 |
D/D |
(731) |
66,959 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
EVP & COO |
• – – |
2016-02-29 |
4 |
D |
$121.58 |
$114,164 |
D/D |
(939) |
66,020 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
EVP & COO |
• – – |
2016-03-07 |
4 |
D |
$127.84 |
$198,152 |
D/D |
(1,550) |
64,470 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
EVP & COO |
• – – |
2016-08-07 |
4 |
D |
$149.02 |
$145,742 |
D/D |
(978) |
59,603 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
EVP & COO |
• – – |
2016-08-09 |
4 |
D |
$150.01 |
$684,796 |
D/D |
(4,565) |
55,038 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
EVP & COO |
• – – |
2017-02-27 |
4 |
D |
$136.97 |
$343,384 |
D/D |
(2,507) |
44,588 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
EVP & COO |
• – – |
2017-03-06 |
4 |
D |
$132.81 |
$238,128 |
D/D |
(1,793) |
52,795 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
EVP & COO |
• – – |
2017-08-07 |
4 |
D |
$155.56 |
$152,138 |
D/D |
(978) |
51,985 |
0 |
- |
|
| AGLE |
Aeglea Biotherapeutics, I... |
Director |
– • – |
2016-04-12 |
4 |
B |
$10.00 |
$70,000 |
D/D |
7,000 |
7,000 |
2.39 |
- |
|
| GOSS |
Gossamer Bio Inc |
Director |
– • – |
2019-02-12 |
4 |
B |
$16.00 |
$115,200 |
D/D |
7,200 |
7,200 |
2.39 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
